Colon Cancer News and Research

Latest Colon Cancer News and Research

Moderate coffee drinking reduces many risks

Although the American Society for Nutrition's popular ,controversy session, at Experimental Biology 2007 focuses on the health effects of coffee drinking, panel chair Dr. James Coughlin, a toxicology/safety consultant at Coughlin & Associates, says that recent advances in epidemiologic and experimental knowledge have transformed many of the negative health myths about coffee drinking into validated health benefits.

1 May 2007

Major new cancer research study

The American Cancer Society is launching a major new cancer research study that may be the ,last best chance, to do large-scale population research in the United States to discover the genetic and environmental factors that cause and prevent cancer.

30 Apr 2007

No data to support leaving small polyps in place

The American Gastroenterological Association (AGA) Institute is eager to increase the number of patients who receive screening for colon cancer.

27 Apr 2007

New mechanism identified for resistance to targeted lung cancer drugs

An international research team, led by investigators from the Massachusetts General Hospital (MGH) Cancer Center and Dana-Farber Cancer Institute (DFCI), has found a new way that some lung tumors become resistant to treatment with targeted therapy drugs like Iressa and Tarceva.

27 Apr 2007

Scientists develop method to convert normal human blood cells into

Cancer researchers led by Dr. John Dick at Ontario Cancer Institute (OCI) have developed a method to convert normal human blood cells into "human" leukemia stem cells.

27 Apr 2007

No evidence that antioxidant supplements interfere with therapeutic effects of chemotherapy agents

There is no evidence that antioxidant supplements interfere with the therapeutic effects of chemotherapy agents, according to a recent systematic review of the use of antioxidants during chemotherapy, available in the May, 2007 issue of the journal Cancer Treatment Reviews.

25 Apr 2007

Virtual Colonoscopy ...safer and cheaper

New technology called "virtual colonoscopy" is promising to offer fewer complications and be more cost-effective than the traditional colonoscopy.

24 Apr 2007

Virtual colonoscopy most cost-effective colon cancer screening test

A new study says targeting smaller (5 mm) lesions does little to significantly reduce the incidence of colorectal cancer (CRC) and, in fact, results in extremely high financial costs and a large proportion of adverse events.

24 Apr 2007

No strong evidence of racial disparities in survival between African-Americans and Caucasians with colon cancer

Correcting social, economic and healthcare inequalities may have the most significant impact in reducing survival differences in colorectal cancer (CRC) between African Americans and Caucasians, according to a new study.

24 Apr 2007

New methods for treating lung cancer cells that have become resistant to new anti-cancer agents

Researchers at the Ireland Cancer Center of University Hospitals Case Medical Center have developed methods for treating lung cancer cells that have become resistant to new anti-cancer agents.

24 Apr 2007

Novel targeted therapy effectively treats acute leukemia

Researchers from the Children's Cancer Hospital at The University of Texas M. D. Anderson Cancer Center have found that a novel targeted therapy effectively treats acute leukemia in animal models by preventing cancer cells from being purged of damaged proteins.

20 Apr 2007

New discoveries about stem cells in leukemia, breast and colon cancer

Recent discoveries about the role of stem cells in cancer have altered the landscape of cancer research. With each new study, scientists are learning more about cancer-initiating properties of stem cells at organ sites and throughout the body.

19 Apr 2007

Oncolytics Biotech researchers demonstrate reovirus/gemcitabine

Oncolytics Biotech announced that a poster by Dr. Maureen E. Lane et al. of Cornell University, New York , entitled "In Vivo Synergy between Oncolytic Reovirus and Gemcitabine in Ras-Mutated Human HCT116 Xenografts" was presented at the American Association for Cancer Research (AACR) Annual Meeting in Los Angeles, CA.

18 Apr 2007